0001562180-24-002401.txt : 20240307 0001562180-24-002401.hdr.sgml : 20240307 20240307161839 ACCESSION NUMBER: 0001562180-24-002401 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blackley Richard Scott CENTRAL INDEX KEY: 0001525020 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40154 FILM NUMBER: 24730381 MAIL ADDRESS: STREET 1: 1680 CAPITAL ONE DRIVE CITY: MCLEAN STATE: VA ZIP: 22102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oscar Health, Inc. CENTRAL INDEX KEY: 0001568651 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 403-3677 MAIL ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: Mulberry Health Inc. DATE OF NAME CHANGE: 20130204 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-03-05 false 0001568651 Oscar Health, Inc. OSCR 0001525020 Blackley Richard Scott 75 VARICK STREET, 5TH FLOOR NEW YORK NY 10013 false true false false Chief Financial Officer false Class A Common Stock 2024-03-05 4 M false 62500.00 A 641359.00 D Class A Common Stock 2024-03-06 4 S false 27043.00 14.12 D 614316.00 D Restricted Stock Units 2024-03-05 4 M false 62500.00 0.00 D Class A Common Stock 62500.00 187500.00 D Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 to $14.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter. /s/ Melissa Curtin, Attorney-in-fact 2024-03-07